Similar outcome of elderly patients in Intergroup Trial 0096
Open Access
- 30 October 2000
- Vol. 89 (9) , 1953-1960
- https://doi.org/10.1002/1097-0142(20001101)89:9<1953::aid-cncr11>3.0.co;2-6
Abstract
No abstract availableKeywords
Funding Information
- BMS
- Eli Lilly
- Biogen
- NeoRx
- Glaxo
This publication has 16 references indexed in Scilit:
- Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and EtoposideNew England Journal of Medicine, 1999
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- The influence of age on the delivery, tolerance, and efficacy of thoracic irradiation in the combined modality treatment of limited stage small cell lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Five-Day Oral Etoposide2 Treatment for Advanced Small-Cell Lung Cancer: Randomized Comparison With Intravenous ChemotherapyJNCI Journal of the National Cancer Institute, 1997
- Age and the treatment of lung cancer.Thorax, 1996
- Treatment of small cell lung carcinoma in the elderlyCancer, 1996
- Treatment of Small Cell Lung Cancer in the ElderlyJournal of the American Geriatrics Society, 1994
- A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung CancerNew England Journal of Medicine, 1992
- Retrospective review of chemotherapy for small cell lung cancer in the elderly: Does the end justify the means?European Journal of Cancer and Clinical Oncology, 1991
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958